Nine Chapters Capital Management’s Emergent Biosolutions EBS Stock Holding History

Nine Chapters Capital Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-10,700	Closed	-$311K	–	91
2017 Q1	$311K	Buy	10,700 +600	+6%	+$18.3K	0.42%	96
2016 Q4	$332K	Buy	+10,100	New	+$303K	0.56%	66
2015 Q4	–	Sell	-56,400	Closed	-$1.61M	–	166
2015 Q3	$1.61M	Buy	56,400 +15,600	+38%	+$514K	0.14%	201
2015 Q2	$1.34M	Buy	+40,800	New	+$1.26M	0.11%	268
2015 Q1	–	Sell	-16,800	Closed	-$457K	–	1001
2014 Q4	$457K	Buy	+16,800	New	+$400K	0.04%	561
2014 Q2	–	Sell	-36,500	Closed	-$922K	–	976
2014 Q1	$922K	Buy	+36,500	New	+$922K	0.11%	282

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Nine Chapters Capital Management's EBS Position: Q2 2017 in Review

Nine Chapters Capital Management sold out of Emergent Biosolutions (EBS) in Q2 2017, closing a stake of 10,700 shares — an estimated $311K sold.

Nine Chapters Capital Management first reported a position in EBS in Q1 2014 and held it in 6 quarters. The position peaked at $1.61M in Q3 2015. 181 funds tracked by Wall St. Rank hold EBS as of Q2 2017.

Nine Chapters Capital Management reported no remaining Emergent Biosolutions position as of Q2 2017 after selling out during the quarter.
Nine Chapters Capital Management sold 10,700 Emergent Biosolutions shares in Q2 2017, an estimated $311K.
Nine Chapters Capital Management first reported a position in Emergent Biosolutions in Q1 2014 and held it in 6 quarters.
Nine Chapters Capital Management's Emergent Biosolutions position peaked at $1.61M in Q3 2015.
181 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2017.

Based on Nine Chapters Capital Management's 13F filing for Q2 2017, filed 31 Jul 2017.